Health ❯ Healthcare ❯ Pharmaceuticals

Drug Safety

Mifepristone Medication Recall Counterfeit Medications Product Recalls Contaminated Drugs Recalls Adverse Effects Quality Control Product Recall Side Effects

18 ARTICLES

3w ago

Manufacturer Recalls Generic Zyrtec Over Possible Ranitidine Contamination

Visible red dots on pills prompted a recall that warns undeclared ranitidine could trigger life‑threatening allergic reactions in hypersensitive people.

3 ARTICLES

3w ago

FDA Grants Priority Review to Pfizer’s Talzenna Plus Xtandi for HRR-Altered mCSPC

13 ARTICLES

last mo.

More Than 2.5 Million Lupin Eye Drop Bottles Recalled Nationwide

4 ARTICLES

last mo.

Regulators Move to Strip Approval of Tavneos After Trial Misconduct and Liver Safety Signals

4 ARTICLES

last mo.

Six Victorians Suffer Acute Liver Toxicity After Using Illegal Peptide Labelled Retatrutide

4 ARTICLES

last mo.

Anvisa Orders Recall of Three Injectable Drug Lots After Contamination and Quality Failures

6 ARTICLES

last mo.

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

3 ARTICLES

2mo ago

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

3 ARTICLES

2mo ago

Anvisa Orders Seizure of Falsified Growth Hormone and Stolen Cancer Drug

4 ARTICLES

2mo ago

FDA Orders New Kidney Warning for Orlistat Weight‑Loss Pills

5 ARTICLES

2mo ago

Haleon Recalls Four Lots of Gas‑X Extra Strength Softgels

5 ARTICLES

2mo ago

Mexico to Reroute Interoceanic Train Track to Bypass Sharp 'Orejas de Conejo' Curves

9 ARTICLES

2mo ago

FDA Launches Retrospective Safety Study of Mifepristone

6 ARTICLES

2mo ago

Anvisa Suspends Enalapril and Halaven Lots After Manufacturers Report Quality and Labeling Faults

3 ARTICLES

2mo ago

EMA Recommends Etcamah for ESR1‑Mutant Advanced Breast Cancer

7 ARTICLES

2mo ago

Japan Orders Warning for Tabneos After 20 Deaths Linked to Liver Dysfunction

Drug Safety

Manufacturer Recalls Generic Zyrtec Over Possible Ranitidine Contamination

FDA Grants Priority Review to Pfizer’s Talzenna Plus Xtandi for HRR-Altered mCSPC

More Than 2.5 Million Lupin Eye Drop Bottles Recalled Nationwide

Regulators Move to Strip Approval of Tavneos After Trial Misconduct and Liver Safety Signals

EMA Committee Recommends Revoking Tavneos Authorization

FDA Classifies Chlorthalidone Recall as Class II

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

India Bans 16 Fixed‑Dose Combination Drugs

Six Victorians Suffer Acute Liver Toxicity After Using Illegal Peptide Labelled Retatrutide

Anvisa Orders Recall of Three Injectable Drug Lots After Contamination and Quality Failures

Never miss stories about

Drug Safety

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

Anvisa Orders Seizure of Falsified Growth Hormone and Stolen Cancer Drug

FDA Orders New Kidney Warning for Orlistat Weight‑Loss Pills

Haleon Recalls Four Lots of Gas‑X Extra Strength Softgels

Mexico to Reroute Interoceanic Train Track to Bypass Sharp 'Orejas de Conejo' Curves

FDA Launches Retrospective Safety Study of Mifepristone

Anvisa Suspends Enalapril and Halaven Lots After Manufacturers Report Quality and Labeling Faults

EMA Recommends Etcamah for ESR1‑Mutant Advanced Breast Cancer

Japan Orders Warning for Tabneos After 20 Deaths Linked to Liver Dysfunction

Never miss stories about

Drug Safety